Tumor-infiltrating lymphocytes (TILs), including CD8+ T cells and CD4+ helper T1 lymphocytes, are related to positive outcomes, whereas CD4+ helper T2 lymphocytes are linked to unfavorable patient survival (250). Here, CD4 is linked to neoplasm.